Nasopharyngeal carcinoma radiotherapy with hybrid technique

被引:17
|
作者
Akbas, Ugur [1 ]
Koksal, Canan [1 ]
Kesen, Nazmiye Donmez [1 ]
Ozkaya, Kubra [2 ]
Bilge, Hatice [1 ]
Altun, Musa [2 ]
机构
[1] Istanbul Univ, Oncol Inst, Div Med Phys, Istanbul, Turkey
[2] Istanbul Univ, Med Fac, Div Radiat Oncol, Istanbul, Turkey
关键词
Nasopharyngeal cancer; IMRT; VMAT; Hybrid; MODULATED ARC THERAPY; RADIATION-THERAPY; IMRT; TUMOR; VMAT;
D O I
10.1016/j.meddos.2018.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the study was to investigate the effect of the Hybrid technique which was created by combining of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nasopharyngeal cancer (NPC) patients. 7 to 9 field IMRT, triple arc VMAT, and Hybrid plans were generated for 10 advanced stage NPC patients. The homogeneity index (HI) and the conformity index (CI) of planning target volumes (PTVs) were calculated for each technique to evaluate the plan quality. The techniques were compared in terms of plan quality, sparing of organs at risk (OARs), monitor units (MUs), and delivery time. Hybrid technique significantly improved the target dose homogeneity and the conformity for PTV70 and PTV60 compared to IMRT and VMAT. Hybrid plans significantly reduced the maximum dose of the brainstem sparing compared to the VMAT plans and also improved the sparing of spinal cord compared to IMRT and VMAT. The MUs and the delivery time of Hybrid plans were found to be between values for IMRT and VMAT plans. Hybrid technique can be useful when IMRT and VMAT techniques are not adequate alone in the treatment of NPC patients. (C) 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 50 条
  • [41] Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Şükran Ülger
    Zekeriya Ülger
    Ferah Yildiz
    Enis Özyar
    Medical Oncology, 2007, 24 : 91 - 94
  • [42] RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA - AN ANALYSIS OF THE SITE OF FAILURE
    RABEN, D
    LEE, J
    LEE, DJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 249 - 249
  • [43] Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients
    Chen, YP
    Tsang, NM
    Tseng, TK
    Hung, JH
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S166 - S166
  • [44] Epilepsy related to radiotherapy in patients with nasopharyngeal carcinoma
    Tang, Yamei
    Li, Yi
    Luo, Donghua
    Rong, Xiaoming
    Ye, Jianhong
    Peng, Ying
    EPILEPSY RESEARCH, 2011, 96 (1-2) : 24 - 28
  • [45] Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Ulger, Sukran
    Ulger, Zerkeriya
    Yildiz, Ferah
    Ozyar, Enis
    MEDICAL ONCOLOGY, 2007, 24 (01) : 91 - 94
  • [46] Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma
    Li, Ying
    Chen, Xiaochuan
    Wu, Lishui
    Huang, Zongwei
    Xu, Siqi
    Hong, Xinyi
    Lai, Jinghua
    Qiu, Sufang
    Zheng, Xiong
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [47] STEREOTACTIC RADIOTHERAPY FOR LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA
    Leung, To-Wai
    Wong, Victy Y. W.
    Tung, Stewart Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 734 - 741
  • [48] Carotid stenosis after radiotherapy for nasopharyngeal carcinoma
    Cheng, SWK
    Ting, ACW
    Lam, LK
    Wei, WI
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2000, 126 (04) : 517 - 521
  • [49] Stereotactic radiotherapy in nasopharyngeal carcinoma - Preliminary results
    Dhanachai, M
    Kraiphibul, P
    Pochanugool, L
    Dangprasert, S
    Sitathanee, C
    Laothamatas, J
    Kulapraditharom, B
    Theerapancharoen, V
    Sirisinha, T
    Yongvithisatid, P
    Assavaprathuangkul, P
    Boonpitak, K
    RADIOSURGERY, VOL 4, 2002, 4 : 162 - 166
  • [50] Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma
    Yeo, Eugenia L. L.
    Li, You Quan
    Soo, Khee-Chee
    Wee, Joseph T. S.
    Chua, Melvin L. K.
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (02)